Recent studies have highly investigated alternatives to current anti-obesity treatments, targeting natural inhibitors of pancreatic lipase, a key enzyme in the digestion of dietary fats. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.